Synapse - Gary Schwartz

Results (19)

Measuring tumor response and shape change on CT: Esophageal cancer as a paradigm

Journal Article

Schwartz, L. H.; Colville, J. A. C.; Ginsberg, M. S.; Wang, L.; Mazumdar, M.; Kalaigian, J.; Hricak, H.; Ilson, D.; Schwartz, G. K.
Annals of Oncology (2006)

Fulltext@MSK | Save

17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates the G(2)/M cell cycle checkpoint by down-regulating chk1 and selectively sensitizes tumor cells with defective p53 to topoisomerase I poison

Meeting Abstract

Tse, A. N.; Solit, D.; Rosen, N.; Schwartz, G.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Response assessment parameters in esophageal cancer - Conventional and novel techniques

Meeting Abstract

Schwartz, L. H.; Colville, J. A. C.; Wang, L.; Hricak, H.; Ilson, D.; Schwartz, G. K.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma

Journal Article

Casper, E. S.; Schwartz, G. K.; Sugarman, A.; Leung, D.; Brennan, M. F.
Journal of Clinical Oncology (1997)

Fulltext@MSK | Save

Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil

Journal Article

Kelsen, D.; Karpeh, M.; Schwartz, G.; Gerdes, H.; Lightdale, C.; Botet, J.; Lauers, G.; Klimstra, D.; Huang, Y.; Saltz, L.; more...
Journal of Clinical Oncology (1996)

Fulltext@MSK | Save

The protein kinase C specific inhibitor safingol in combination with chemotherapy induces apoptosis in gastric cancer cells that have mutated or wild-type p53 genes

Meeting Abstract

Schwartz, G. K.; Dhupar, S. K.; Haimovitz-Friedman, A.; Ehleiter, D.; Maslak, P.; Loganzo, F.; Kelsen, D.; Fuks, Z.; Albino, A. P.
Proceedings of the American Association for Cancer Research Annual Meeting (1995)

Fulltext@MSK | Save

Does the combination of neoadjuvant chemotherapy and postoperative intraperitoneal therapy increase perioperative complications in patients with gastric adenocarcinoma?

Meeting Abstract

Reynolds, J. V.; Karpeh, M. S. Jr; Kelsen, D.; Hans, G.; Schwartz, G.; Garcia, C.; Rodriguez, J.; Newman, E.; Brennan, M. F.
Gastroenterology (1995)

Fulltext@MSK | Save

Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells

Journal Article

Schwartz, G. K.; Haimovitz-Friedman, A.; Dhupar, S. K.; Ehleiter, D.; Maslak, P.; Lai, L.; Loganzo, F. Jr; Kelsen, D. P.; Fuks, Z.; Albino, A. P.
JNCI: Journal of the National Cancer Institute (1995)

Fulltext@MSK | Save

Edatrexate in patients with soft tissue sarcoma: Activity in malignant fibrous histiocytoma

Journal Article

Casper, E. S.; Christman, K. L.; Schwartz, G. K.; Johnson, B.; Brennan, M. F.; Bertino, J. R.
Cancer (1993)

Fulltext@MSK | Save